FDA Inspection 1117142 - Niagara Pharmaceuticals Inc - February 07, 2020

Record Details

This FDA Inspection record concerns Niagara Pharmaceuticals Inc, with an inspection on February 7, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Niagara Pharmaceuticals Inc
Inspection Date: February 7, 2020
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · dbc973f2-edee-4f9c-a795-0718e8a091a2

Violation Codes2

21 CFR 211.19221 CFR 211.63

Full citation text and observation details available on the Dashboard.